The Integrated Health & Wellbeing (IHW) Council is set to organize the Lung Health & Oncology National Conference 2024 on December 7, 2024, at the Ambedkar International Convention Centre in New Delhi.
The event’s organizers have highlighted its focus on preventive measures, early detection, and cutting-edge treatment methods. The conference aims to foster collaboration and innovation, leading to significant improvements in lung cancer management.
Lung cancer ranks as the fourth most prevalent cancer in India, with The Lancet citing an annual incidence of 72,510 cases and 66,279 fatalities.
Notable speakers at the conference will include:
– Kamal Narayan, CEO of the IHW Council
– Dr. Saroj Das Majumder, leading the radiation oncology department at AIIMS, Bhubaneshwar
– Col. Rajeev Mannali, CEO of SUT Pattom Super Speciality Hospital
– Mohammed Yahya, director of the CEO’s Office at Qure.ai
– Dr. Charu Bahl, Scientific Affairs Manager at Medgenome Labs
– Dr. Moushumi Suryavanshi, Head of Molecular Biology and Cytogenetics
– Dr. Anant Mohan from AIIMS Delhi
– Col. (Dr.) Shafin Babu from the Department of Pulmonary-Critical Care, Command Hospital, Eastern Command, Kolkata
– Dr. Sridhar P. S., a radiation oncologist
– Dr. Belal Bin Asaf of Medanta – The Medicity, Gurugram
– Dr. Aditya Murali from Apollo Hospitals
– Dr. Subodh Kumar of AIIMS Deoghar
– Dr. Navneet Singh from PGIMER
– Vandana Mahajan, lead counselor of Lung Connect
– Vivek Tomar, co-founder of Rise To Survive Cancer
– Dr. Urvashi Prasad, a former director at Niti Aayog
The conference will include sessions discussing the patterns of lung cancer in India, raising public awareness, and the critical role of screening and infrastructure in lowering disease prevalence. Discussions will also address how AI is revolutionizing lung cancer detection by improving early diagnosis, particularly in resource-constrained areas. Additionally, the presentation of molecular biomarkers is anticipated to provide essential insights into tumor biology for timely and personalized treatment.
A specific session will examine the latest developments in treating non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Experts will explore the practical application of international guidelines and innovative treatments, alongside addressing the challenges they present within the Indian healthcare context. The event seeks to identify gaps in lung cancer care and discover regional inequalities alongside actionable solutions, including the contributions of patient advocacy groups towards achieving equitable healthcare.
Kamal Narayan Omer, founder and CEO of the IHW Council, stressed the importance of the gathering by stating, “Lung cancer is among the gravest health challenges facing the nation today. This pressing issue requires immediate and united attention from all involved parties. Our conference offers a pivotal platform for experts, innovators, and policymakers to unite in addressing innovative solutions for lung cancer care. By emphasizing new diagnostic technologies, early detection strategies, and equitable access to tailored treatments, we aim to pave the way for improved outcomes and a more robust healthcare infrastructure. We must make meaningful advancements and restore hope to the patients and families grappling with this challenging condition.”